The role of probiotics in reducing the risk of preterm morbidity has been carried out in Scandinavian countries. The risk of preterm birth affects many pregnant women, so it is extremely important to take care of both the mother and the baby, whose immune system, which is not fully developed, cannot 100% defend itself against the pathogens it encounters every day.

The study, which was carried out in Finland, involved nearly 100 babies born between 32 and 36 weeks' gestation. The children were divided into three groups - the first received prebiotics, the second probiotics and the third a placebo. The results showed that the children who received probiotics and prebiotics had a lower incidence of viral infections than the group of children who received neither. Children who received prebiotics became ill much less often - none of the children who received prebiotics became ill more than three times. Researchers indicate that early administration of probiotics and prebiotics can effectively prevent viral upper respiratory tract infections caused by rhinoviruses. There are a number of products on the market containing probiotics and prebiotics, which are recommended from the first days of life. It is best to consult a doctor or pharmacist to select the right product with the most optimal strain of probiotic or prebiotic bacteria.